JAGSNPHARM 1:10+ RR trade set up1. Set up: Reversal Trade from support levels
2.Double bottom at support
3. RR: Minimum 1:10
4. Early unconfirmed entry is high rewarding so building position now would b a wise decision
9.35INR
267.21 MINR
2.37 BINR
7.93 M
About JAGSONPAL PHARMACE
Sector
CEO
Manish Gupta
Headquarters
Gurugram
Website
Employees (FY)
940
Founded
1978
ISIN
INE048B01027
FIGI
BBG000CTMHK8
Jagsonpal Pharmaceuticals Ltd. engages in the development and manufacture of intermediate drugs and pharmaceutical formulations. It offers portfolio of drugs focusing on the gynaecology and orthopaedic segments. The company was founded by Jagmohan Singh Kochhar in 1978 and is headquartered in Gurugram, India.
Jagsonpal Pharmaceuticals Ltd Buy Buy Jagsonpal Pharmaceutical.
Buy levels given in Chart with stop Loss and Targets.
Analysis only for educational purpose following Gann Anniversary Date and Price Action.
JAGSNPHA good price action at supportGood consolidation at support line and green candle with good volume yesterday candle.
Swing trade good setup - may go up for few sessions.
JAGSONPAL Pharmaceuticals LongI am eagerly anticipating the approaching breakout of the Pole and Flag pattern in JAGSONPAL Pharmaceuticals.
I am not a registered Sebi analyst. My studies are purely for educational purposes.
Before trading or investing, please consult with your financial advisor. I am not accountable for your pr
#JAGSNPHARMA - Bullish Triangle - with good volume in past.#JAGSNPHARMA - Bullish Triangle - with good volume in past.
Jagson Pal Pharmaceuticals Ltd looks good!Identified a " Continuation Wedge (Bullish) " chart pattern on Jagson Pal Pharmaceuticals Ltd ( NSE:JAGSNPHARM ).
This pattern suggests a potential bullish move in the stock's price, with an expected increase from the current close of 441.85 to a target range of 491.00 - 500.00.
The pattern too
Strong Rejection Candle📌Strong Rejection Candle
✅#Stock to watch
JAGSNPHARM
+ Shallow retest done
+ Rejection candle with high volume
+ Trading above Key EMAs
JAGSNPHARM: Cooling Off for Potential Gains📈 JAGSNPHARM: A Potential Opportunity is Brewing! 🚀
Are you ready for an exciting trading prospect? JAGSNPHARM is showing all the signs of a lucrative setup. Here's what you need to know:
Key Points:
📊 Cooled Off from Highs: JAGSNPHARM has taken a breather after reaching higher levels. This c
Jagsonpal Pharma Strong fundamentals
Period of Consolidation
Flag type setup
2 prior attempts to break out from GANN level
Cool give 18 - 25% in the next 3 months
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of JAGSNPHARM is 321.45 INR — it has increased by 11.89% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange JAGSONPAL PHARMACE stocks are traded under the ticker JAGSNPHARM.
JAGSONPAL PHARMACE is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track JAGSONPAL PHARMACE financials in yearly and quarterly reports right on TradingView.
Like other stocks, JAGSNPHARM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JAGSONPAL PHARMACE stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 940.00 employees. See our rating of the largest employees — is JAGSONPAL PHARMACE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JAGSONPAL PHARMACE EBITDA is 258.35 M INR, and current EBITDA margin is 14.95%. See more stats in JAGSONPAL PHARMACE financial statements.